Novo Integrated Sciences Management
Management criteria checks 4/4
Novo Integrated Sciences' CEO is Rob Mattacchione, appointed in Oct 2018, has a tenure of 5.5 years. total yearly compensation is $185.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 13.55% of the company’s shares, worth $1.58M. The average tenure of the management team and the board of directors is 2 years and 3.1 years respectively.
Key information
Rob Mattacchione
Chief executive officer
US$185.0k
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 5.5yrs |
CEO ownership | 13.5% |
Management average tenure | 2yrs |
Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump
Apr 18Novo Integrated Sciences prices 4M unit public offering at $.50/unit
Oct 14Novo Integrated Sciences expects to report over fivefold increase in Q3 revenue
Jul 11Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?
Nov 23Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Aug 07Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Mar 02CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Feb 29 2024 | n/a | n/a | -US$12m |
Nov 30 2023 | n/a | n/a | -US$14m |
Aug 31 2023 | US$185k | US$185k | -US$13m |
May 31 2023 | n/a | n/a | -US$32m |
Feb 28 2023 | n/a | n/a | -US$35m |
Nov 30 2022 | n/a | n/a | -US$35m |
Aug 31 2022 | US$185k | US$185k | -US$33m |
May 31 2022 | n/a | n/a | -US$12m |
Feb 28 2022 | n/a | n/a | -US$9m |
Nov 30 2021 | n/a | n/a | -US$5m |
Aug 31 2021 | US$47k | US$47k | -US$4m |
Compensation vs Market: Rob's total compensation ($USD185.00K) is below average for companies of similar size in the US market ($USD674.64K).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Mattacchione (55 yo)
5.5yrs
Tenure
US$185,000
Compensation
Mr. Robert Mattacchione, also known as Rob, is Chairman of the Board and Chief Executive Officer at Novo Integrated Sciences, Inc. since October 2018. He serves as Co-Owner at Mattacchione Family Trust. He...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 5.5yrs | US$185.00k | 13.55% $ 1.2m | |
COO & Director | 2.8yrs | US$434.56k | 0.043% $ 3.8k | |
President | less than a year | US$81.03k | no data | |
Principal Financial Officer & Principal Accounting Officer | less than a year | no data | no data | |
Chief Medical Officer & Chairman of Medical Advisory Board | 2yrs | no data | no data |
2.0yrs
Average Tenure
57yo
Average Age
Experienced Management: NVOS's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 5.5yrs | US$185.00k | 13.55% $ 1.2m | |
COO & Director | 9.7yrs | US$434.56k | 0.043% $ 3.8k | |
Chief Medical Officer & Chairman of Medical Advisory Board | 3yrs | no data | no data | |
Member of Medical Advisory Board | 3yrs | no data | no data | |
Independent Director | 3.3yrs | US$126.37k | 0% $ 0 | |
Independent Director | 3.3yrs | US$91.18k | 0% $ 0 | |
Member of Medical Advisory Board | 3yrs | no data | no data | |
Independent Director | 1.8yrs | US$71.37k | 0% $ 0 |
3.1yrs
Average Tenure
52yo
Average Age
Experienced Board: NVOS's board of directors are considered experienced (3.1 years average tenure).